Equity Investing
Why is Statera Biopharma, Inc. (STAB) experiencing a decrease in premarket?
Statera Biopharma, Inc. (STAB) experienced a decrease of 8.48% in the premarket. However, the last trading session closed at $2.24 with an increase of 1.82%.